Eine Liste der molekularen Ringversuchsprogramme, die von QCMD angeboten werden, wird unten angezeigt (in Englisch).
Für weitere Informationen oder für die Teilnahmeregistrierung melden Sie sich bitte in Ihrem QCMD-Teilnehmerprofilbereich
(QCMD Participant Profile Area) an. Wenn Sie noch keinen Benutzernamen (Username) und Passwort (Password) für Ihr Login haben, klicken Sie bitte hier.
Click to view / hide
Blood Borne Virus
B19 virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV034116_1 | QAV034116_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 8 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
HBV Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV124160_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV134167_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HIV Dried Blood Spot EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV214221_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV024131_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV114146_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV-1 DNA EQA programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV034114_1 | QAV034114_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 8 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Hepatitis A virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV124156_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis B Virus DNA EQA Programme
Feature | Available Formats | ||
---|---|---|---|
Catalogue Number | QAV994110_1 | QAV994110_2 | QAV994110_4 |
Total Number of Challenges | 1 | 2 | 4 |
Number of Panel Members | 8 | 4 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Hepatitis B Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV214223_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis B virus Genotype EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064118_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis C Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV214222_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis C Virus RNA EQA Programme
Feature | Available Formats | ||
---|---|---|---|
Catalogue Number | QAV994112_1 | QAV994112_2 | QAV994112_4 |
Total Number of Challenges | 1 | 2 | 4 |
Number of Panel Members | 8 | 4 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Hepatitis C virus Genotype EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV034117_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis D Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144170_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
Hepatitis E virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV124157_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
Human Immunodeficiency Virus RNA EQA Programme
Feature | Available Formats | ||
---|---|---|---|
Catalogue Number | QAV994108_1 | QAV994108_2 | QAV994108_4 |
Total Number of Challenges | 1 | 2 | 4 |
Number of Panel Members | 8 | 4 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Human Immunodeficiency Virus Type 2 EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV204212_1 | QAV204212_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 8 | 4 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Click to view / hide
Central Nervous System
Arthropod-Borne Viruses EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAM194206_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
BK virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV144166_1 | QAV144166_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Borrelia burgdorferi spp. DNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB114147_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV174195_1 | QAV174195_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM174196_1 | QAM174196_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Chikungunya Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV154175_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Dengue Virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV114148_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Enterovirus RNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV984104_1 | QAV984104_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Enterovirus Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164185_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Herpes simplex virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV994105_1 | QAV994105_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
JC virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV074106_1 | QAV074106_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Measles and Mumps EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144171_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Parechovirus RNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV114145_1 | QAV114145_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Varicella-Zoster virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV034103_1 | QAV034103_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
West Nile Virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV104141_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Zika Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164186_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Congenital Infections
Cytomegalovirus Dried Blood Spot EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064127_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Drug Resistance
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Extended Spectrum β-lactamase and Carbapenemase EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB134162_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
HBV Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV124160_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV134167_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV024131_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV114146_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Methicillin Resistant Staphylococcus aureus DNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB064124_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Mycobacterium Tuberculosis Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB194209_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Vancomycin Resistant Enterococci EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB134163_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Exotic / Emerging Diseases
Plasmodium spp. (Malaria) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214218_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Arthropod-Borne Viruses EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAM194206_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Babesia spp. (Babesiosis) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214219_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Chikungunya Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV154175_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Dengue Virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV114148_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Francisella tularensis EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAB214220_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
MERS Coronavirus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV154181_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Poxviruses EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV224225_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Respiratory I Plus EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM204216_1A | QAM204216_1B |
Total Number of Challenges | 1 | 1 |
Number of Panel Members | 10 | 10 |
Distribution / Testing Period | Q2 | Q4 |
SARS-CoV-2 Antigen Testing EQA Programme
Feature | Available Formats | |||
---|---|---|---|---|
Catalogue Number | QAS214224_1A | QAS214224_1B | QAS214224_1C | QAS214224_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
SARS-CoV-2 EQA Programme
Feature | Available Formats | |||
---|---|---|---|---|
Catalogue Number | QAV204215_1A | QAV204215_1B | QAV204215_1C | QAV204215_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
West Nile Virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV104141_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Yellow Fever Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV194207_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Zika Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164186_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Gastrointestinal Diseases
Adenovirus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV054133_1 | QAV054133_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Bacterial Gastroenteritis EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB124153_1 | QAB124153_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Clostridium difficile DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB084125_1 | QAB084125_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Diarrheagenic Escherichia coli EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB154179_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Helicobacter pylori EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB164190_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Norovirus RNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV084139_1 | QAV084139_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Parasitic Gastroenteritis EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAP124154_1 | QAP124154_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Viral Gastroenteritis EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV124152_1 | QAV124152_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide
Immunocompromised Associated Diseases
Aspergillus spp. DNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAF104140_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
BK virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV144166_1 | QAV144166_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Babesia spp. (Babesiosis) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214219_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Candida spp. EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAF124151_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Cytomegalovirus Whole Blood EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV124150_1 | QAV124150_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV024121_1 | QAV024121_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus Whole Blood EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV134161_1 | QAV134161_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Cytomegalovirus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV014120_1 | QAV014120_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Herpes Virus 6 DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV084119_1 | QAV084119_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
JC virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV074106_1 | QAV074106_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAF114144_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Torque Teno Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV184203_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 6 |
Distribution / Testing Period | Q4 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Transplantation EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAM174198_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Click to view / hide
Multiple Pathogen/Syndromic
Arthropod-Borne Viruses EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAM194206_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Bacterial Gastroenteritis EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB124153_1 | QAB124153_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV174195_1 | QAV174195_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM174196_1 | QAM174196_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB174191_1 | QAB174191_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
MALDI-TOF EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB124155_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Parasitic Gastroenteritis EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAP124154_1 | QAP124154_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Respiratory I EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV164188_1 | QAV164188_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory I Plus EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM204216_1A | QAM204216_1B |
Total Number of Challenges | 1 | 1 |
Number of Panel Members | 10 | 10 |
Distribution / Testing Period | Q2 | Q4 |
Respiratory II EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV164189_1 | QAV164189_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory III EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM174193_1 | QAM174193_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Sepsis EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB164178_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Sexually Transmitted Infections I EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB154177_1 | QAB154177_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Sexually Transmitted Infections II EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM174201_1 | QAM174201_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Transplantation EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAM174198_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Viral Gastroenteritis EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV124152_1 | QAV124152_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide
Respiratory Diseases
Adenovirus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV054133_1 | QAV054133_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Atypical Mycobacterium EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB194208_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q1 |
Bordetella pertussis DNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB094132_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Chlamydia psittaci EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB134165_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Chlamydophila pneumoniae EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB084107_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Coronavirus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064137_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Group A Streptococcus (GAS) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAB234226_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Influenza Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064138_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
Influenza virus A and B RNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV054134_1 | QAV054134_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Legionella spp. EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB044122_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q1 |
MERS Coronavirus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV154181_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Measles and Mumps EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144171_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Metapneumovirus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV054135_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q2 |
Mycobacterium Tuberculosis Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB194209_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Mycobacterium tuberculosis DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB014129_1 | QAB014129_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Mycoplasma pneumoniae EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB174192_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Parainfluenza Virus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064136_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAF114144_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Respiratory I EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV164188_1 | QAV164188_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory I Plus EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM204216_1A | QAM204216_1B |
Total Number of Challenges | 1 | 1 |
Number of Panel Members | 10 | 10 |
Distribution / Testing Period | Q2 | Q4 |
Respiratory II EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV164189_1 | QAV164189_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory III EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM174193_1 | QAM174193_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory Syncytial Virus RNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV054142_1 | QAV054142_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Rhinovirus RNA EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064143_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
SARS-CoV-2 Antigen Testing EQA Programme
Feature | Available Formats | |||
---|---|---|---|---|
Catalogue Number | QAS214224_1A | QAS214224_1B | QAS214224_1C | QAS214224_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
SARS-CoV-2 EQA Programme
Feature | Available Formats | |||
---|---|---|---|---|
Catalogue Number | QAV204215_1A | QAV204215_1B | QAV204215_1C | QAV204215_1D |
Total Number of Challenges | 1 | 1 | 1 | 1 |
Number of Panel Members | 5 | 5 | 5 | 5 |
Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
Click to view / hide
Sexually Transmitted Infections
Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB174191_1 | QAB174191_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Herpes simplex virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV994105_1 | QAV994105_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Human Papillomavirus (Preservcyt) EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV094130_1 | QAV094130_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 12 | 6 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Human Papillomavirus (Surepath) EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV184204_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 12 |
Distribution / Testing Period | Q3 |
Mycoplasma genitalium EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB184205_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Sexually Transmitted Infections I EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAB154177_1 | QAB154177_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Sexually Transmitted Infections II EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAM174201_1 | QAM174201_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Syphilis EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB154180_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Trichomonas vaginalis EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAP184202_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Click to view / hide
Transplant Associated Diseases
Adenovirus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV054133_1 | QAV054133_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
BK virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV144166_1 | QAV144166_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Cytomegalovirus Whole Blood EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV124150_1 | QAV124150_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV024121_1 | QAV024121_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus Whole Blood EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV134161_1 | QAV134161_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Cytomegalovirus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV014120_1 | QAV014120_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Herpes Virus 6 DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV084119_1 | QAV084119_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
JC virus DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAV074106_1 | QAV074106_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q4 | Q2 & Q4 |
Torque Teno Virus EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV184203_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 6 |
Distribution / Testing Period | Q4 |
Toxoplasma gondii DNA EQA Programme
Feature | Available Formats | |
---|---|---|
Catalogue Number | QAP044123_1 | QAP044123_2 |
Total Number of Challenges | 1 | 2 |
Number of Panel Members | 10 | 5 |
Distribution / Testing Period | Q3 | Q1 & Q3 |
Transplantation EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAM174198_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q2 |
Click to view / hide
Typing
Bacterial 16S EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB164183_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Cytomegalovirus Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV144169_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q2 |
Enterovirus Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164185_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
HBV Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV124160_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV134167_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV024131_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV114146_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q4 |
Hepatitis B virus Genotype EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064118_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Hepatitis C virus Genotype EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV034117_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q1 |
Herpes Simplex Virus Drug Resistance EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV164184_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q1 |
Influenza Typing EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAV064138_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q4 |
MALDI-TOF EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB124155_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies) EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB074128_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Staphylococcus aureus spa EQA Programme
Feature | Available Formats |
---|---|
Catalogue Number | QAB134164_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 6 |
Distribution / Testing Period | Q3 |
Click to view / hide
EQA Pilots
Plasmodium spp. (Malaria) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214218_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Babesia spp. (Babesiosis) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214219_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Francisella tularensis EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAB214220_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Group A Streptococcus (GAS) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAB234226_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
HIV Dried Blood Spot EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV214221_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis B Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV214223_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Hepatitis C Virus Dried Blood Spot EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV214222_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 8 |
Distribution / Testing Period | Q3 |
Poxviruses EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV224225_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAP214217_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |
Viral Metagenomics NGS EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAV204213_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 5 |
Distribution / Testing Period | Q3 |
Click to view / hide
New Programme
Joint Infection EQA Pilot Study
Feature | Available Formats |
---|---|
Catalogue Number | QAM244227_1 |
Total Number of Challenges | 1 |
Number of Panel Members | 10 |
Distribution / Testing Period | Q3 |